Regent Pacific Group (HKSE:00575) FFO


HKSE:00575 Regent Pacific Group Ltd HKSE:00575
12 GF Score
Price HK$0.92
GF Value HK$0.56
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Regent Pacific Group FFO?

FFO (Funds from operations) only applies to REITs.

HKSE:00575
12GF Score
Regent Pacific Group Ltd HKSE:00575
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Regent Pacific Group (HKSE:00575) Overvalued in 2026?

Based on GuruFocus' analysis, Regent Pacific Group stock appears to be overvalued. The current stock price of HK$0.92 is trading 64.3% above its estimated GF Value™ of HK$0.56. GuruFocus considers Regent Pacific Group to be Significantly Overvalued.

Key valuation signals for HKSE:00575:

  • FFO:
  • GF Value™: HK$0.56 vs. price of HK$0.92 (64.3% above fair value)
  • GF Score™: 12/100 with 7 warning signs

No single metric tells the full story. See the HKSE:00575 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Regent Pacific Group Business Description

Other Exchanges RPG:Germany
Address 5 Queen\'s Road Central, 8th Floor, Henley Building, Hong Kong, HKG
Regent Pacific Group Ltd is an investment holding company that runs through two segments: Biopharma and Corporate Investment. Its Biopharma segment is engaged in the research, development, manufacturing, marketing, and sales of pharmaceutical products, and it also develops artificial intelligence (AI) systems for the field of biological aging clocks. The Corporate Investment segment is engaged in the investment in listed and unlisted corporate entities. The majority of its revenue comes from the Biopharma segment. Geographically, the Europe; U.S.; and Asia Pacific. It derives maximum revenue from Europe.
12GF Score

Get the complete analysis for HKSE:00575

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.92
Price
HK$0.56
GF Value